These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 11005621

  • 1. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P, Andoljsek D, Mlakar U, Pretnar J, Modic M, Zupan IP, Zver S.
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [Abstract] [Full Text] [Related]

  • 2. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Černelč P, Andoljšek D, Mlakar U, Pretnar J, Modic M, Zupan IP, Zver S.
    Pflugers Arch; 2000 Jan; 440(Suppl 1):R081-R082. PubMed ID: 28008490
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G, Ahlin A, Dahllöf G, Elinder G, Henter JI, Palmblad J.
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost considerations in therapy with myeloid growth factors.
    Glaspy JA, Jakway J.
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S19-26. PubMed ID: 7689789
    [Abstract] [Full Text] [Related]

  • 6. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
    Bhana N.
    Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ, Plard JP, Wells MY, Zerial A, Roquet F.
    Cancer Chemother Pharmacol; 1997 Jul; 39(3):259-66. PubMed ID: 8996530
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A, Saito H, Toyama K, Horiuchi A, Kuriya S, Furusawa S, Tsuruoka N, Takiguchi T, Matsuda T, Utsumi M, Shiku H, Matsui T, Egami K, Tamura K, Ohno R.
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of recombinant human granulocyte/macrophage-colony-stimulating factor (rHu GM-CSF) and rHu G-CSF administration on neutrophil chemiluminescence assay in patients following cyclic chemotherapy.
    Aslan M, Yucel G, Bozcuk H, Savas B.
    Cancer Immunol Immunother; 1998 Nov; 47(3):176-81. PubMed ID: 9829843
    [Abstract] [Full Text] [Related]

  • 12. Comparison of lenograstim and filgrastim on haematological effects after autologous peripheral blood stem cell transplantation with high-dose chemotherapy.
    Kim IH, Park SK, Suh OK, Oh JM.
    Curr Med Res Opin; 2003 Nov; 19(8):753-9. PubMed ID: 14687447
    [Abstract] [Full Text] [Related]

  • 13. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
    Kuritzkes DR.
    Clin Infect Dis; 2000 Feb; 30(2):256-60. PubMed ID: 10671324
    [Abstract] [Full Text] [Related]

  • 14. Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma.
    Hashino S, Morioka M, Irie T, Shiroshita N, Kawamura T, Suzuki S, Iwasaki H, Umehara S, Kakinoki Y, Kurosawa M, Kahata K, Izumiyama K, Kobayashi H, Onozawa M, Takahata M, Fujisawa F, Kondo T, Asaka M.
    Int J Lab Hematol; 2008 Aug; 30(4):292-9. PubMed ID: 18665826
    [Abstract] [Full Text] [Related]

  • 15. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
    Heussner P, Haase D, Kanz L, Fonatsch C, Welte K, Freund M.
    Int J Hematol; 1995 Dec; 62(4):225-34. PubMed ID: 8589368
    [Abstract] [Full Text] [Related]

  • 16. Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia.
    Quintas-Cardama A, Kantarjian H, O'Brien S, Garcia-Manero G, Rios MB, Talpaz M, Cortes J.
    Cancer; 2004 Jun 15; 100(12):2592-7. PubMed ID: 15197801
    [Abstract] [Full Text] [Related]

  • 17. Effect of granulocyte colony-stimulating factor on granulopoiesis of congenital neutropenic children.
    Benkö I, Maródi L, Megyeri A, Káposzta R, Kovács P.
    Acta Physiol Hung; 1996 Jun 15; 84(3):261-2. PubMed ID: 9219597
    [Abstract] [Full Text] [Related]

  • 18. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V, Ongun H, Yeşilipek MA, Yeğin O.
    Turk J Pediatr; 1999 Jun 15; 41(1):117-20. PubMed ID: 10770686
    [Abstract] [Full Text] [Related]

  • 19. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
    Lamberti JS, Bellnier TJ, Schwarzkopf SB, Schneider E.
    J Clin Psychiatry; 1995 Jun 15; 56(6):256-9. PubMed ID: 7539786
    [Abstract] [Full Text] [Related]

  • 20. Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization.
    Orciuolo E, Buda G, Marturano E, Mauro E, Milone G, Cangialosi C, Di Renzo N, Pastore D, Specchia G, De Paolis MR, Mazza P, Pietrantuono G, Petrini M.
    Leuk Res; 2011 Jul 15; 35(7):899-903. PubMed ID: 21134693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.